Ampreloxetine

Unassigned

New Medicines

Symptomatic neurogenic orthostatic hypotension (snOH)

Information

New molecular entity
Theravance Biopharma
Theravance Biopharma

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Noradrenaline reuptake inhibitor
OH is very common, especially in the elderly, due to a number of underlying problems with BP control. Causes include autonomic failure, Parkinson disease, diabetes [2].
Symptomatic neurogenic orthostatic hypotension (snOH)
Oral